News Sentiment

BFRI sentiment intelligence

Biofrontera Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1.10 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+8.9% over one week, +27.2% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04 - Liquidity Sweep

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 8.9% Price confirming higher
Trend fit Trend active 27.2% over four weeks
Fair value -42.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 34
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
TradingKey 8
GlobeNewswire 4
Quartr 3
dars.gov.et 2
Stock Titan 2
DonanımHaber 2
Market source 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 17
Guidance 2
Balance sheet 1
Analyst action 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 45
TradingView Direct company coverage

Enterprise value to EBIT forward of Biofrontera Inc. – NASDAQ:BFRI

This article focuses on the enterprise value to EBIT forward of Biofrontera Inc., traded on NASDAQ under the ticker BFRI. It is primarily a data page from TradingView, indicating financial metrics for the pharmaceutical company. The content provided is minimal, serving mainly as

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 10:40
Source
TradingView
MLQ.ai Direct company coverage

Frontier tech research, news & data

The article provides a detailed growth snapshot of Biofrontera Inc. (BFRI), covering its revenue, net income, and EPS growth rates year-over-year. It presents both annual and quarterly growth data from FY2019 to Q1 FY26, highlighting the company's financial performance trends. Th

Tone
Positive 76/100
Event
Earnings
Published
10 Jul 2026 02:10
Source
MLQ.ai
Quartr Direct company coverage

Biofrontera (BFRI) AGM 2026 Summary

Biofrontera (BFRI) held its 2026 Annual General Meeting, where directors and key executives participated remotely. The agenda included proposals for electing two Class II directors, amending the 2021 Omnibus Incentive Plan, and ratifying the independent auditor. The meeting summa

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 12:10
Source
Quartr
TradingView Direct company coverage

Enterprise value to EBITDA forward of Biofrontera Inc. – NASDAQ:BFRI

This article displays information regarding Biofrontera Inc. (NASDAQ: BFRI)'s enterprise value to forward EBITDA. The information is presented within a TradingView interface, which provides financial data and tools for market analysis. The content is primarily a data placeholder

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 07:10
Source
TradingView
Quartr Direct company coverage

Biofrontera (BFRI) Q4 2025 earnings summary

Biofrontera (BFRI) reported record annual revenues of $41.7 million in 2025, a 12% increase year-over-year, with Q4 revenues reaching $17.1 million. The company achieved profitability in Q4 with a net income of $5.6 million and adjusted EBITDA of $4.9 million, driven by an asset

Tone
Positive 73/100
Event
Earnings
Published
08 Jul 2026 06:11
Source
Quartr
Quartr Direct company coverage

Biofrontera (BFRI) Proxy filing Summary

Biofrontera (BFRI) has released a summary of its proxy filing for the 2026 Annual Meeting scheduled for June 11, 2026. Key proposals include the election of two Class II directors, an increase in authorized shares for the 2021 Omnibus Incentive Plan, and the ratification of CBIZ

Tone
Positive 61/100
Event
Market update
Published
08 Jul 2026 03:11
Source
Quartr
TradingView Direct company coverage

Price to earnings forward of Biofrontera Inc. – NASDAQ:BFRI

This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-earnings forward metric. It appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analysis or numerical values fo

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 09:09
Source
TradingView
Stock Titan Direct company coverage

BFRI SEC Filings - Biofrontera Inc 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Biofrontera Inc. (BFRI) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details recent filings from September 2025, highlighting insider beneficial ownership, convertible preferred stock conversions, an

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 00:11
Source
Stock Titan
Finviz Direct company coverage

BFRI - Biofrontera Inc Options

This article provides a detailed financial overview of Biofrontera Inc. (BFRI), including its stock performance, valuation metrics, earnings data, and insider/institutional ownership. It highlights the company's recent stock price of $1.16, a significant percentage change, and ke

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 11:40
Source
Finviz
TradingView Direct company coverage

Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera Financial Disclosures & SEC Filings

This article provides a comprehensive list of Biofrontera Inc.'s financial disclosures and SEC filings, including earnings reports, quarterly and annual reports, and investor conference summaries dating back to 2021. It details key financial metrics, clinical pipeline progress, a

Tone
Positive 71/100
Event
Earnings
Published
02 Jul 2026 07:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Biofrontera Inc. – NASDAQ:BFRI

This article provides financial information for Biofrontera Inc. (NASDAQ: BFRI), specifically its price-to-sales forward ratio. The content, sourced from TradingView, indicates that the market was closed at the time of publication and no trades were recorded. It offers an overvie

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 08:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Biofrontera Inc. – NASDAQ:BFRI

This article provides a brief financial overview of Biofrontera Inc. (NASDAQ: BFRI), focusing on its price to book forward metric. It indicates that the market was closed at the time of publication and no trades were made. The content is primarily a financial data point without f

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 00:42
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Biofrontera, Inc. – MUN:AI10

The article title indicates a focus on the enterprise value to revenue forward ratio for Biofrontera, Inc. (MUN:AI10). The content found only contains this title and navigation information. No financial data or analysis is presented within the provided text.

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 15:40
Source
TradingView
TradingView Direct company coverage

A3EFRZ Forecast — Price Target — Prediction for 2027

This article provides a forecast for Biofrontera, Inc. (A3EFRZ), including a 1-year price target of 5.11 EUR based on two analyst ratings. It also details recent financial performance, such as last quarter's earnings per share and revenue, and upcoming earnings report dates. The

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 07:41
Source
TradingView
TradingView Direct company coverage

AI10 Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Biofrontera, Inc. (AI10) stock, based on analyst opinions, including maximum and minimum price estimates. It also details the company's financial performance, such as recent earnings and revenue, historical stock prices, and i

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 02:10
Source
TradingView
TradingView Direct company coverage

Biofrontera, Inc. Actuals & Estimates (NASDAQ:BFRI)

This article provides an overview of Biofrontera Inc. (NASDAQ: BFRI) stock, including its current price, historical performance, analyst forecasts, and financial data. It covers frequently asked questions regarding its stock ticker, price changes, market capitalization, earnings

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 10:09
Source
TradingView
TradingView Direct company coverage

BFRI Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Biofrontera Inc. (BFRI) stock, incorporating analyst ratings, historical performance, and financial data. It addresses frequently asked questions about the stock's current price, volatility, market capitalization, earnings, an

Tone
Positive 61/100
Event
Analyst action
Published
26 Jun 2026 08:42
Source
TradingView
TradingView Direct company coverage

Price to book forward of Biofrontera Inc. – NASDAQ:BFRIW

The article focuses on the "Price to book forward" financial metric for Biofrontera Inc. (NASDAQ: BFRIW). It appears to be a stub or a data point from a financial platform like TradingView, showing the value and change of this specific metric for the company. The content itself p

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 04:41
Source
TradingView
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Financial Health: Profitability & Balance Sheet Analysis

Biofrontera Inc (BFRI) has a weak financial status but high operating efficiency, with a current financial score of 7.82, ranking 98 out of 157 in the Pharmaceuticals industry. The company recently reported a 17.42% year-over-year increase in quarterly revenue to $10.08M and a 13

Tone
Neutral 50/100
Event
Earnings
Published
23 Jun 2026 18:40
Source
TradingKey
Sahm Direct company coverage

Biofrontera Inc.'s (NASDAQ:BFRI) Path To Profitability

Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company, is projected by analysts to reach profitability in 2027, with an anticipated breakeven point just over a year from the article's publication. This forecast relies on an optimistic annual growth rate of 63%. The company,

Tone
Positive 62/100
Event
Guidance
Published
20 Jun 2026 17:11
Source
Sahm
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Institutional Confidence

This article from TradingKey provides an overview of Biofrontera Inc's (BFRI) institutional confidence score and shareholder activity as of June 18, 2026. It lists key institutional shareholders, the number of shares they hold, and the percentage change in their holdings. The com

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 04:10
Source
TradingKey
TradingKey Direct company coverage

Biofrontera Inc (BFRIW) Shareholder Structure: Major Shareholders & Institutional Holdings

The article provides a detailed breakdown of Biofrontera Inc's (BFRIW) shareholder structure, including categories of shareholders and institutional holdings over several recent quarters. It lists major institutional investors and their changes in shareholding, offering insights

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 07:46
Source
TradingKey
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Valuation: PE, PB & Fair Value Analysis

Biofrontera Inc (BFRI) currently has a valuation score of 9.06, placing it 54th out of 157 in the Pharmaceuticals industry. Its P/E ratio stands at -1.01, which is significantly below its recent high but above its recent low. The company has not yet disclosed relevant data for P/

Tone
Negative 40/100
Event
Market update
Published
18 Jun 2026 07:39
Source
TradingKey
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a historical overview of Biofrontera Inc's (BFRI) dividend distributions and stock split events. It notes that the company has not distributed any dividends in the past five years. However, it details multiple 20-for-1 merger-related stock splits that occurre

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Biofrontera Inc (BFRI), listing major shareholders and their proportions, including Rosalind Advisors, Inc. and AIGH Capital Management, LLC. It also breaks down shareholder types such as hedge funds and individual investors. Addi

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Biofrontera Inc. (BFRI), detailing its segment and regional revenue contributions. However, it notes that relevant data for fiscal years 2021-2025 has not yet been disclosed by the company. The only specific financial detail provided

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 01:39
Source
TradingKey
Stock Titan Direct company coverage

Biofrontera (NASDAQ: BFRI) OKs directors, bigger incentive plan and auditor

Biofrontera Inc. (BFRI) held its Annual Meeting of Stockholders on June 11, 2026, where shareholders approved several key proposals. They elected Beth J. Hoffman and Kevin D. Weber as Class II directors, significantly increased the authorized shares for the 2021 Omnibus Incentive

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 19:39
Source
Stock Titan